| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue |
-
|
-
|
-
| | Cost of Revenue |
-
|
-
|
-
| | | Gross Profit |
-
|
-
|
-
| | | Operating Expenses | | Research Development | 59,277 | 31,362 | 22,268 | | Selling General and Administrative | 13,417 | 9,567 | 4,127 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (72,694) | (40,929) | (26,395) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,822 | 2,212 | 822 | | Earnings Before Interest And Taxes | (70,872) | (38,717) | (25,574) | | Interest Expense | 2,056 | 1,343 | 235 | | Income Before Tax | (72,928) | (40,060) | (25,809) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (72,928) | (40,060) | (25,809) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (72,928) | (40,060) | (25,809) | | Preferred Stock And Other Adjustments |
-
| (5,575) | (4,729) | | | Net Income Applicable To Common Shares | ($72,928) | ($45,635) | ($30,538) |
|
0.34% Nasdaq 
0.06 (0.66%) 
Income Statement
